Comparative Meta-Analysis of Retatrutide Versus Placebo and Dulaglutide for Weight Loss and Diabetes Management: Insights From Clinical Trials

MeSH terms

• Diabetes Mellitus, Type 2* / drug therapy
• Fatty Acids
• Glucagon-Like Peptides* / adverse effects
• Glucagon-Like Peptides* / analogs & derivatives
• Glucagon-Like Peptides* / therapeutic use
• Humans
• Hypoglycemic Agents* / therapeutic use
• Immunoglobulin Fc Fragments* / adverse effects
• Immunoglobulin Fc Fragments* / therapeutic use
• Peptides
• Randomized Controlled Trials as Topic*
• Recombinant Fusion Proteins* / administration & dosage
• Recombinant Fusion Proteins* / therapeutic use
• Treatment Outcome
• Weight Loss* / drug effects